A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

How blockchain is powering a $25 B decentralized AGI initiative, shifting control from major tech companies to ...

Call them dire wolves. Don’t call them dire wolves. Colossal Biosciences, the biotechnology company from Dallas, Texas, that ...